Interacoustics is excited to introduce a new, free online onboarding resource designed to help clinicians get the most from their Eclipse evoked potentials system. The platform brings together essential product training in one accessible hub, supporting both new and experienced...
Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...
Cochlear Implantation (CI) in children with single-sided deafness (SSD) is a controversial treatment option. Profs Karen Gordon, Papsin and Cushing discuss the rationale and early findings on the relative success of achieving binaural hearing for SSD with CI. If you’d...
By Harvey Coates, Clinical Professor University of Western AustraliaThe 14th Frontiers in Otolaryngology, Head and Neck Surgery was held in Hobart, Tasmania and sponsored by the Passe and Williams Foundation (formerly known the Garnett Passe and Rodney Williams Memorial Foundation)....
Professor Maria Suurna, International Coordinator of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), is hosting
a complimentary Global Grand Rounds Webinar on Saturday 26 July, 9.00 – 10.30am.
‘Checklists’ in the operating room make for safer surgery, better handovers and improved patient care. Can we apply the principles we have learned since Atul Gawande and the WHO pioneered this approach to surgery to our own wellbeing as doctors,...
This single blinded RCT compared 43 patients with 50 symptomatic keloids that were randomised to two matched groups of 25 scars, receiving either 5-fluorouracil (5-FU) or current first line treatment, triamcinolone (TAC). The surgeon administering the injectable treatments was unblinded,...
6 August 2024
| Andrew C Swift, Ray Clarke
|
ENTA - General
It is with great sadness that we record the passing of Max McCormick, a treasured friend and an eminent and greatly valued colleague. Max was a larger-than-life charismatic character who was both loved and esteemed by the entire UK ENT...
Neuromod Devices Ltd, the Irish medical device company which specialises in neuromodulation technologies, has announced the establishment of Neuromod USA Inc., a subsidiary headquartered in Oak Brook, Illinois.
Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...